Illumina | ILMN - Interest Expense On Debt


Illumina reported $25M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 2M Dec/2025
Bio Techne USD 2.18M 173K Jun/2025
Bio-Rad Laboratories USD 12.3M 100K Sep/2025
Boston Scientific USD 90M 3M Dec/2025
Bruker USD 20M 4.3M Sep/2025
Charles River Laboratories USD 23.78M 1.63M Dec/2025
Danaher USD 55M 12M Dec/2025
Dentsply International USD 22M 1000K Dec/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Hologic USD 27.6M 1000K Dec/2025
Illumina USD 25M 0 Sep/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
Laboratory Of America USD 55M 1000K Dec/2025
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Quidel USD 5.68B 5.63B Sep/2025
Repligen USD 5.5M 81K Dec/2025
Revvity USD 23.51M 742K Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 365M 18M Dec/2025
Waters USD 8.62M 18.02M Dec/2025